IASO Bio Announces CT103A Granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track (FT) Designations by the FDA ...Middle East

SAN JOSE, Calif. and SHANGHAI and NANJING, China, Feb. 12, 2023 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, today announced that the U.S....

Hence then, the article about iaso bio announces ct103a granted regenerative medicine advanced therapy rmat and fast track ft designations by the fda was published today ( Monday 13/02/2023 - 03:12 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( IASO Bio Announces CT103A Granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track (FT) Designations by the FDA )

Also on site :

• INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Wix.com Ltd. Investors with Substantial Losses Have Opportunity to Lead the Shareholder Class Action Lawsuit - WIX
• Cult-Favorite Restaurant Chain, With the Country's No. 1 Burger, Makes Major Move In-N-Out Has Always Avoided
• Walmart’s $106 Bookcase Is a Sleek, Modern Heritage Storage Solution for Anyone Who Hates Bulky Furniture